巴西年轻女性四价HPV疫苗普遍接种规划效果
该研究为巴西全国性横断面调查(POP-Brazil研究),于2016年9月至2017年11月在27个联邦单位的119个公共初级保健单位招募5945名16-25岁女性,面对面访谈并采集生殖道样本进行HPV基因分型。结果显示,四价疫苗使HPV 6/11/16/18型总频率从15.64%降至6.76%,降幅56.78%(P<0.01),支持疫苗有效性,但接种者中其他高危型HPV感染率更高(40.47% vs 32.63%,P<0.01)。
要点
- 四价HPV疫苗使6/11/16/18型感染率降低56.78%(15.64%→6.76%)。
- 接种者HPV 16感染率为2.34%,未接种者为8.91%。
- 接种者其他高危型HPV感染率反而更高(40.47% vs 32.63%)。
核心结论
- 研究结果支持巴西HPV疫苗接种的有效性,但需持续监测接种时代的HPV感染率。
研究设计与样本
- 横断面多中心调查(POP-Brazil研究),2016年9月至2017年11月从巴西27个联邦单位119个公共初级保健单位招募5945名16-25岁女性。
主要发现
- 11.92%(95%CI 10.65,13.20)的参与者报告已接种疫苗,接种率在16-17岁女性中最高,随年龄增长而下降,且接种者更可能属于高社会经济地位组。
- 四价疫苗使HPV 6、11、16、18型频率从15.64%降至6.76%,降幅56.78%(P<0.01),调整年龄后仍显著。
- 接种者HPV 16感染率为2.34%,未接种者为8.91%(P<0.01);HPV 6感染率分别为2.06%和5.77%(P<0.01)。
- 接种者其他高危型HPV(非16/18型)感染率为40.47%,未接种者为32.63%(P<0.01)。
临床怎么用
- 支持在年轻女性中推广四价HPV疫苗接种以降低疫苗型HPV感染。
局限性
- 横断面设计无法完全排除混杂因素,且接种状态为自我报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We examined human papillomavirus (HPV) vaccine effectiveness in a nationwide sample of women aged 16 to 25 years who utilized the public health system in Brazil. This was a cross-sectional, multicentric survey conducted between September 2016 and November 2017 (POP-Brazil Study). A total of 5,945 young adult women were recruited from 119 public primary care units from all 27 federative units of Brazil by trained health professionals. The participants participated in a face-to-face interview and provided biological samples for genital HPV analysis. HPV genotyping was performed using a Linear Array HPV genotyping test in a central laboratory. Sampling weights were applied to the data. Overall, 11.92% (95% CI 10.65, 13.20) of the participants reported having been vaccinated. The frequency of vaccination was highest in 16- to 17-year-old women, with a decreasing vaccination rate with increasing age, and vaccinated women were more likely to belong to the high socioeconomic status group. The use of a quadrivalent vaccine decreased the HPV types 6, 11, 16, and 18 by 56.78%, from 15.64% in unvaccinated women to 6.76% in vaccinated women (P < 0.01), even after adjustment for age. Those who received the vaccine had lower HPV 16 (2.34% in vaccinated vs 8.91% in unvaccinated, P < 0.01) and 6 rates (2.06% vs 5.77%, P < 0.01). Additionally, a higher rate of high-risk HPV types other than HPV 16 and 18 (40.47% in vaccinated vs 32.63% in unvaccinated, P < 0.01) was observed. In conclusion, the results of this study support the effectiveness of HPV vaccination in Brazil. Continuous surveillance must be assured to monitor the HPV infection rate in the vaccination era.
引用
- Wendland EM, Kops NL, Bessel M, et al. Effectiveness of a universal vaccination program with an HPV quadrivalent vaccine in young Brazilian women. Vaccine. 2021. PMID: 33674171. doi:10.1016/j.vaccine.2021.02.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。